CNCR stock icon

ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR

$14.61
0.14%
0
Funds holding %
of 6,656 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

8% more capital invested

Capital invested by funds: $1.58M [Q3] → $1.7M (+$129K) [Q4]

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

5.68% less ownership

Funds ownership: 17.97% [Q3] → 12.28% (-5.68%) [Q4]

13% less funds holding

Funds holding: 15 [Q3] → 13 (-2) [Q4]

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

Research analyst outlook

We haven’t received any recent analyst ratings for CNCR.

Financial journalist opinion